Barbara Buldini
Impact in
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
-
- Acute Lymphoblastic Leukemia research
Papers in
- Hematology 39
- Acute Myeloid Leukemia Research 24
- Chronic Myeloid Leukemia Treatments 13
- Hematopoietic Stem Cell Transplantation 13
-
- Acute Lymphoblastic Leukemia research 41
- Co-authors
- Giuseppe BassoMichael DworzakGiuseppe GaipaRichard RateiValentino ConterAndrea BiondiFranco LocatelliLucia De Zen
In The Last Decade
Barbara Buldini
55 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 79
- Hematology 671
- Public Health, Environmental and Occupational Health 630
- Genetics 145
- Pediatrics, Perinatology and Child Health 219
- Pathology and Forensic Medicine 159
Countries citing papers authored by Barbara Buldini
This map shows the geographic impact of Barbara Buldini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Buldini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Buldini more than expected).
Fields of papers citing papers by Barbara Buldini
This network shows the impact of papers produced by Barbara Buldini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Buldini. The network helps show where Barbara Buldini may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Barbara Buldini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2023 | 6 | |
| 3 | 2023 | 5 | |
| 4 | 2023 | 1 | |
| 5 | 2022 | 2 | |
| 6 | 2022 | 13 | |
| 7 | 2021 | 5 | |
| 8 | 2021 | 15 | |
| 9 | 2019 | 29 | |
| 10 | 2018 | 10 | |
| 11 | 2018 | 17 | |
| 12 | 2018 | 9 | |
| 13 | 2017 | 22 | |
| 14 | 2016 | 27 | |
| 15 | 2015 | 47 | |
| 16 | 2011 | 127 | |
| 17 | 2009 | 181 | |
| 18 | 2008 | 19 | |
| 19 | 2005 | 24 | |
| 20 | 2004 | 4 |
About Barbara Buldini
Barbara Buldini is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Pathology and Forensic Medicine, Pediatrics, Perinatology and Child Health and Genetics, having authored 56 papers that have together received 1.2k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (41 papers), Acute Myeloid Leukemia Research (24 papers), Chronic Myeloid Leukemia Treatments (13 papers), Hematopoietic Stem Cell Transplantation (13 papers), Childhood Cancer Survivors' Quality of Life (7 papers), Lymphoma Diagnosis and Treatment (7 papers), CAR-T cell therapy research (4 papers) and Protein Degradation and Inhibitors (4 papers). The work is most often cited by research in Hematology (671 citations), Public Health, Environmental and Occupational Health (630 citations), Genetics (145 citations), Pediatrics, Perinatology and Child Health (219 citations) and Pathology and Forensic Medicine (159 citations). Barbara Buldini has collaborated with scholars based in Italy, Austria and Germany. Frequent co-authors include Giuseppe Basso, Michael Dworzak, Giuseppe Gaipa, Richard Ratei, Valentino Conter, Andrea Biondi, Franco Locatelli, Lucia De Zen, Maria Grazia Valsecchi and Oscar Maglia. Their work appears in journals such as Blood, Pediatric Blood & Cancer, Leukemia, Cytometry Part B Clinical Cytometry and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.